NMD Pharma
Denmark - AarhusPharmaceutical
Focus: NMD Pharma is a Series A-stage small molecule drug discovery company based in Aarhus, Denmark, focused on neurology and rare neuromuscular diseases. The company operates at a micro-cap scale (51-200 employees) with a clinical pipeline in neuromuscular indications.
Profile data last refreshed 4d ago · AI intelligence enriched 3w ago
Funding Stage
SERIES A
Employees
51-200
Total Funding
$47M
Open Jobs
0
About NMD Pharma
AI assessmentNot HiringNo open roles listed right now. Follow NMD Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$165K Part D (pre-launch only)Declining
Post-LOE
Mature generic with widespread resistance; minimal revenue contribution and no innovation upside.
Help build intelligence for NMD Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.